1. Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Issue 3 (March 2023) Authors: Négrier, Claude; Mahlangu, Johnny; Lehle, Michaela; Chowdary, Pratima; Catalani, Olivier; Bernardi, Ronald J; Jiménez-Yuste, Víctor; Beckermann, Benjamin M; Schmitt, Christophe; Ventriglia, Giuliana; Windyga, Jerzy; d'Oiron, Roseline; Moorehead, Paul; Koparkar, Sunita; Teodoro, Vanda; Shapiro, Am... Journal: Lancet Issue: Volume 10:Issue 3(2023) Page Start: e168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗